Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease

Evid Based Med. 2015 Apr;20(2):77. doi: 10.1136/ebmed-2014-110121. Epub 2015 Jan 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Coronary Artery Bypass / economics*
  • Coronary Artery Bypass / methods*
  • Coronary Artery Disease*
  • Drug-Eluting Stents / economics*
  • Female
  • Humans
  • Male
  • Percutaneous Coronary Intervention / economics*
  • Percutaneous Coronary Intervention / methods*